BDBM750802 US20250195521, Example A278

SMILES CCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)N1CC([C@@H](C)OC)C1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2

InChI Key InChIKey=GKXRKCHEHGLYMA-UHFFFAOYSA-N

Data  12 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 750802   

TargetGTPase KRas [G12D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase KRas [G12C](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase KRas [G12V](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase KRas [G13C](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase KRas [G12V](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase KRas(Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

Targetkras g13d(Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase KRas [Q61H](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase NRas [G12C](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase NRas(Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase NRas [Q61K](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetGTPase NRas [Q61R](Human)
Revolution Medicines

US Patent
LigandPNGBDBM750802(US20250195521, Example A278)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent